Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies ; volume:56 ; number:1 ; day:4 ; month:1 ; year:2024 ; pages:86-94 ; date:1.2024
Experimental & molecular medicine ; 56, Heft 1 (4.1.2024), 86-94, 1.2024
- Urheber
-
Seo, Dong-oh
Holtzman, David M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s12276-023-01146-2
- URN
-
urn:nbn:de:101:1-2024041510011672646304
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Seo, Dong-oh
- Holtzman, David M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
PU.1 regulates Alzheimer’s disease-associated genes in primary human microglia
Alzheimer’s disease-associated complement gene variants influence plasma complement protein levels
Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood
The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
Elucidating the mechanisms underlying Alzheimer's disease-associated genetic polymorphisms
Alzheimer disease : therapeutic strategies
Elevated expression of the retrotransposon LINE-1 drives Alzheimer’s disease-associated microglial dysfunction
Genetic correlations between Alzheimer’s disease and gut microbiome genera
Neuritic Plaques — Gateways to Understanding Alzheimer’s Disease
Rho GTPases as therapeutic targets in Alzheimer’s disease
DUBs in Alzheimer’s disease: mechanisms and therapeutic implications
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
PU.1 regulates Alzheimer’s disease-associated genes in primary human microglia
Alzheimer’s disease-associated complement gene variants influence plasma complement protein levels
Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood
The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
Elucidating the mechanisms underlying Alzheimer's disease-associated genetic polymorphisms
Alzheimer disease : therapeutic strategies
Elevated expression of the retrotransposon LINE-1 drives Alzheimer’s disease-associated microglial dysfunction
Genetic correlations between Alzheimer’s disease and gut microbiome genera
Neuritic Plaques — Gateways to Understanding Alzheimer’s Disease
Rho GTPases as therapeutic targets in Alzheimer’s disease
DUBs in Alzheimer’s disease: mechanisms and therapeutic implications
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
PU.1 regulates Alzheimer’s disease-associated genes in primary human microglia
Alzheimer’s disease-associated complement gene variants influence plasma complement protein levels
Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood
The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
Elucidating the mechanisms underlying Alzheimer's disease-associated genetic polymorphisms
Alzheimer disease : therapeutic strategies
Elevated expression of the retrotransposon LINE-1 drives Alzheimer’s disease-associated microglial dysfunction
Genetic correlations between Alzheimer’s disease and gut microbiome genera
Neuritic Plaques — Gateways to Understanding Alzheimer’s Disease
Rho GTPases as therapeutic targets in Alzheimer’s disease